These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10513323)

  • 1. Quantitative EEG findings associated with chronic stimulant and cannabis abuse and ADHD in an adult male substance use disorder population.
    Trudeau DL; Thuras P; Stockley H
    Clin Electroencephalogr; 1999 Oct; 30(4):165-74. PubMed ID: 10513323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Clinical Gains and Side Effects of Stimulant Medication in Pediatric Attention-Deficit/Hyperactivity Disorder by Combining Measures From qEEG and ERPs in a Cued GO/NOGO Task.
    Ogrim G; Kropotov JD
    Clin EEG Neurosci; 2019 Jan; 50(1):34-43. PubMed ID: 29940782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence.
    Notzon DP; Mariani JJ; Pavlicova M; Glass A; Mahony AL; Brooks DJ; Grabowski J; Levin FR
    Am J Addict; 2016 Dec; 25(8):666-672. PubMed ID: 28051838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project.
    Leuchter AF; McGough JJ; Korb AS; Hunter AM; Glaser PE; Deldar A; Durell TM; Cook IA
    J Psychiatr Res; 2014 Jul; 54():11-8. PubMed ID: 24726639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome.
    Aharonovich E; Garawi F; Bisaga A; Brooks D; Raby WN; Rubin E; Nunes EV; Levin FR
    Am J Drug Alcohol Abuse; 2006; 32(4):629-35. PubMed ID: 17127551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?
    Biederman J; Wilens TE; Mick E; Faraone SV; Spencer T
    Biol Psychiatry; 1998 Aug; 44(4):269-73. PubMed ID: 9715358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
    Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
    Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder.
    Groenman AP; Oosterlaan J; Rommelse NN; Franke B; Greven CU; Hoekstra PJ; Hartman CA; Luman M; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Br J Psychiatry; 2013 Aug; 203(2):112-9. PubMed ID: 23846996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between patterns of cannabis use, abuse and dependence and recent stimulant use: Evidence from two national surveys in Ireland.
    Millar SR; Mongan D; O'Dwyer C; Smyth BP; Perry IJ; Galvin B
    PLoS One; 2021; 16(8):e0255745. PubMed ID: 34370775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of stimulant medications on the EEG of children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive type.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Brown CR; Croft RJ
    Int J Psychophysiol; 2003 Feb; 47(2):129-37. PubMed ID: 12568943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey.
    Kolla NJ; van der Maas M; Toplak ME; Erickson PG; Mann RE; Seeley J; Vingilis E
    BMC Psychiatry; 2016 Feb; 16():50. PubMed ID: 26920911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.
    Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP
    J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of stimulant medications on children with attention-deficit/hyperactivity disorder and excessive beta activity in their EEG.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Clarke DC; Croft RJ
    Clin Neurophysiol; 2003 Sep; 114(9):1729-37. PubMed ID: 12948803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study.
    Biederman J; Petty CR; Monuteaux MC; Mick E; Clarke A; Ten Haagen K; Faraone SV
    J Child Psychol Psychiatry; 2009 Mar; 50(3):352-8. PubMed ID: 19309331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study.
    Biederman J; Wilens T; Mick E; Faraone SV; Weber W; Curtis S; Thornell A; Pfister K; Jetton JG; Soriano J
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):21-9. PubMed ID: 9000777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.